Target intelligence / Profile preview

Solute carrier family 29 member 4 pseudogene 2 (SLC29A4P2)

Target
SLC29A4P2
Molecular classification
Other, Pseudogene (does not encode a molecular target)
01

Overview

SLC29A4P2 (solute carrier family 29 member 4 pseudogene 2) is a pseudogene annotated in the human genome. Unlike protein-coding genes of the SLC29 family (such as SLC29A4, which encodes the equilibrative nucleoside transporter 4, and is implicated in monoamine and nucleoside transport relevant to neurological functions), SLC29A4P2 does not produce a functional protein and thus has no established biological role, disease association, or drug targeting relevance. The presence of “pseudogene” in its designation means it represents a genomic remnant with sequence similarity to SLC29A4 but lacks the capacity to encode a transporter or other protein product[2][6][8]. This entry is considered not a valid molecular target for therapy, research, or diagnostic purposes. If your interest is in active transporter proteins, examine related functional homologs such as SLC29A4 (Equilibrative nucleoside transporter 4, ENT4)[5][7][9], or other SLC29 family members.

Other names
SLC29A4P2Solute carrier family 29 (nucleoside transporters), member 4 pseudogene 2Solute carrier family 29 member 4 pseudogene 2
02

Mechanism of action

None

03

Biological functions

None (no proven biological activity; pseudogenes lack protein-coding function)
04

Disease associations

None (no association with disease roles; pseudogenes are generally not implicated directly unless specifically documented)

Beyond the preview

Go deeper on Solute carrier family 29 member 4 pseudogene 2 (SLC29A4P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 29 member 4 pseudogene 2 (SLC29A4P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call